Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

REGENXBIO Inc. - Common Stock (NQ:RGNX)

11.60 +0.59 (+5.36%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,606,186
Open 10.81
Bid (Size) 11.00 (100)
Ask (Size) 11.62 (200)
Prev. Close 11.01
Today's Range 10.60 - 11.78
52wk Range 5.035 - 16.19
Shares Outstanding 43,466,186
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kaplan Fox Alerts Investors of REGENXBIO Inc. (RGNX) to an Investigation of Possible Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox Alerts Investors of REGENXBIO Inc. (RGNX) to an Investigation of Possible Securities Law Violations
Via TheNewswire.com

Performance

YTD
-14.5%
-14.5%
1 Month
-18.9%
-18.9%
3 Month
-9.7%
-9.7%
6 Month
+32.6%
+32.6%
1 Year
+52.6%
+52.6%

More News

Read More
RGNX Shares Pare Losses As Wall Street Dismisses Gene Therapy Clinical Hold Spurred Selloff As An Overreaction ↗
Via Stocktwits
Gapping stocks in Wednesday's session ↗
Via Chartmill
News headline image
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy? ↗
Via Stocktwits
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Analyst Expectations For Regenxbio's Future ↗
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
Via Benzinga
Top movers in Wednesday's pre-market session ↗
Via Chartmill
News headline image
My Top 4 Stocks to Buy in Early 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
Via MarketMinute
News headline image
REGENXBIO (RGNX) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
REGENXBIO INC (NASDAQ:RGNX) Tops Q3 2025 Estimates, Shares Rise on Strong Results and Pipeline Progress ↗
Via Chartmill
News headline image
The Analyst Verdict: Regenxbio In The Eyes Of 7 Experts ↗
Via Benzinga
News headline image
7 Analysts Assess Regenxbio: What You Need To Know ↗
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Regenxbio Through 6 Analysts ↗
Via Benzinga
News headline image
Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date ↗
Via Benzinga
News headline image
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
News headline image
FDA Extends Decision Date On Regenxbio's Gene Therapy Into Next Year ↗
Via Benzinga
News headline image
REGENXBIO INC (NASDAQ:RGNX) Reports Q2 2025 Earnings Miss, Stock Slides Amid Revenue and EPS Shortfalls ↗
Via Chartmill
Topics Earnings
News headline image
A Glimpse Into The Expert Outlook On Regenxbio Through 8 Analysts ↗
Via Benzinga
News headline image
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Early Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, Longer ↗
Via Benzinga
News headline image
Dow Dips Over 100 Points; US Jobless Claims Increase ↗
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is REGENXBIO Inc. - Common Stock publicly traded?
Yes, REGENXBIO Inc. - Common Stock is publicly traded.
What exchange does REGENXBIO Inc. - Common Stock trade on?
REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for REGENXBIO Inc. - Common Stock?
The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market
What is the current price of REGENXBIO Inc. - Common Stock?
The current price of REGENXBIO Inc. - Common Stock is 11.60
When was REGENXBIO Inc. - Common Stock last traded?
The last trade of REGENXBIO Inc. - Common Stock was at 01/29/26 04:00 PM ET
What is the market capitalization of REGENXBIO Inc. - Common Stock?
The market capitalization of REGENXBIO Inc. - Common Stock is 504.21M
How many shares of REGENXBIO Inc. - Common Stock are outstanding?
REGENXBIO Inc. - Common Stock has 504M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.